Wobenzym® is an enzyme preparation, which could be known as systemic protease therapy. It was introduced in Germany in the 1960s by the Medical Enzyme Research Foundation. Todays Wobenzym®Med, a professional product packaged and distributed exclusively by health professionals, is backed by over 1,000 documented cases, some of which even provide initial information at a molecular level. Focused on treating causes, Wobenzym®Med successfully treats: Tumor Illnesses, Infections, Injuries, Autoimmune diseases, Rheumatic diseases, Vascular diseases, & Inflammations. (See Enzymes, A Drug of the Future, by Wrba, ISBN 3-609-51280-6)
A months supply of Wobenzym®Med (280 tablets) costs $52.00. To become familiar with Enzyme Therapy, we recommend the interesting and easy to read book: Enzymes, The Fountain of Life, by Lopez and consider reading the books: Enzymes, A Drug of the Future by Dr. Heinrich Wrba, and Oral Enzymes, A New Approach to Cancer Treatment, by F. Klaschka.
Acting synergistically with Beyond Chelation, Wobenzym®Med substantially reduces the incidence of fatal blood clots now known to be induced by the sudden breakdown of vulnerable plaque
Increases feelings of well-being because of its antioxidant and cholesterol lowering effects
Allows fewer heart attacks or strokes because of Wobenzym®Meds anti-thrombotic, anti-spasmodic and anti-arrhythmic abilities
Greater patient longevity due to the control of many of the molecular bases of aging
With Beyond Chelation, Wobenzym®Med improves results with arterial blockages caused by Herpes, CMV, Homocysteine and other molecular based causes
Provides protection from environmental toxins in the air, water and food
Offers an opportunity for continuing long-term survival and long-term improvement in health
Used to treat Autoimmune Diseases, Rheumatic Diseases, Vascular Diseases, Inflammations, Injuries, Infections, and Tumor Illnesses
Improves
the functioning of all body organs/systems



View all Webinars
You are about to visit a third-party site. We are not responsible for the information contained on third-party sites. Do you wish to continue?